Bahamas vs Iran: Cause of death, by other COVID-19 pandemic-related outcomes, female
Cause of death, by other COVID-19 pandemic-related outcomes, female over time
- Bahamas
- Iran
How they compare
Bahamas currently reports 5.6% against 5.3% in Iran, a difference of 0.3%.
That makes Bahamas's figure about 1.1 times Iran's.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Iran ahead.
Bahamas ranks 18th and Iran ranks 21st of 185 countries.
Iran has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahamas | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 3.9% | 4.0% | 0.1% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by other covid-19 pandemic-related outcomes, female, Bahamas or Iran?
- Bahamas, at 5.6% against 5.3% in Iran as of 2021.
- What is the difference in cause of death, by other covid-19 pandemic-related outcomes, female between Bahamas and Iran?
- 0.3%, with Bahamas ahead.
- How many years of comparable data are there for Bahamas and Iran?
- 6 years are reported by both, from 2000 to 2021.
- How do Bahamas and Iran rank globally for cause of death, by other covid-19 pandemic-related outcomes, female?
- Bahamas ranks 18th and Iran ranks 21st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by other COVID-19 pandemic-related outcomes, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to other COVID-19 pandemic-related outcomes divided by number of all female deaths, expressed by percentage. Other COVID-19 pandemic-related outcomes capture all deaths due to the pandemic which were not specifically caused by COVID-19 or indirect COVID-19 causes. These are estimated by subtracting COVID-19-specific deaths and deaths attributed to indirect COVID-19 causes from total excess mortality.